Neuronetics Inc. (STIM), a Malvern, Pennsylvania-based medical technology company, on Tuesday announced that President and Chief Executive Officer Keith Sullivan will step down effective March 23 and retire on March 31, after more than five years in the role.
The company said Dan Reuvers has been appointed as President and Chief Executive Officer, effective March 23, and will also join the board of directors.
Reuvers most recently served as President and CEO of Tactile Medical and previously held senior leadership roles at Integra LifeSciences and other medical technology companies.
The company said Reuvers' experience in scaling medical technology businesses and driving growth is expected to support its next phase of expansion.
The company also granted Reuvers 1.5 million restricted stock units as an inducement award, vesting over three years under the company's 2020 Inducement Incentive Plan.
In the pre-market trading, Neuronetics is 9.55% higher at $1.4899 on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
Business News
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.